Colorectal cancer information for patients
Finding the right information about colorectal cancer can be difficult. We are here as your allies, to share the latest information about treatment options and support. We understand because we’ve been there and we're here to help you every step of the way. Below are helpful resources to guide you.
What is a colorectal cancer patient?
A colorectal cancer patient is a person who has been diagnosed with the disease at any stage. As a patient, you need information to advocate for yourself.
Where do I begin?
As a patient, you may be faced with a lot of information to process. Give yourself time to learn new words and terms, and be good to yourself as you make your way through this new territory.
Colorectal cancer basics
Below are some of the topics you may need to learn about during your initial diagnosis.
Treatment options
Treatment plans vary from case to case, and depend on the location of the tumor and the stage of diagnosis.
Surgical options
Surgery for colorectal cancer involves a surgeon removing the diseased portion of your colon and/or rectum.
Chemotherapy, radiation, and other therapies
Your doctor may recommend chemotherapy, radiation, or other therapies to treat the cancer.
Colostomy or ileostomy
Colostomies and ileostomies are surgically created openings in the skin of the abdomen that are connected to the small or large intestine.
Clinical trials
Finding a clinical trial can be intimidating, but we are here to help you explore your options.
Biomarkers
Biomarkers for colorectal cancer are used for diagnosis, progression, prognosis, and for treatment.
Finding support
Whether you're newly diagnosed, in treatment, a caregiver, or a survivor, having support is essential. Our Patient and Family Support program is a useful tool for providing resources specific to the journey you're on. Remember, we're here for you every step of the way.
Up next
Related readingTop resources
FDA approves immunotherapy for MSI-H/dMMR stage II & III rectal cancer
The U.S. Food and Drug Administration approved dostarlimab (brand name Jemperli) as the first and only immunotherapy for adults with stage II or III rectal cancer that has a biomarker called MSI-H or dMMR.
FDA approves Tecentriq for some people with stage III colon cancer
The FDA has approved Tecentriq (atezolizumab), given with chemotherapy after surgery, for people with stage III colon cancer whose tumors are mismatch repair deficient (dMMR). It’s the first immunotherapy approved for this use.
Why I answer the phone: A cancer care navigator's view
Meet Paige Edmonds, a social worker behind the Alliance's helpline — and the personal loss that led her there.